Envestnet Asset Management Inc. Sells 1,651 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Envestnet Asset Management Inc. trimmed its stake in shares of Avanos Medical, Inc. (NYSE:AVNS) by 1.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 114,169 shares of the company’s stock after selling 1,651 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.25% of Avanos Medical worth $2,274,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Tidal Investments LLC acquired a new position in shares of Avanos Medical in the 1st quarter worth approximately $439,000. BNP Paribas Financial Markets lifted its holdings in Avanos Medical by 314.4% in the first quarter. BNP Paribas Financial Markets now owns 53,583 shares of the company’s stock valued at $1,067,000 after buying an additional 40,653 shares during the period. Tributary Capital Management LLC boosted its position in Avanos Medical by 7.5% during the first quarter. Tributary Capital Management LLC now owns 742,455 shares of the company’s stock valued at $14,782,000 after acquiring an additional 51,865 shares during the last quarter. Boston Partners acquired a new stake in Avanos Medical during the 1st quarter worth about $571,000. Finally, Quest Partners LLC bought a new position in shares of Avanos Medical in the 2nd quarter worth about $444,000. 95.17% of the stock is owned by institutional investors and hedge funds.

Avanos Medical Stock Up 0.8 %

Shares of NYSE:AVNS opened at $23.21 on Friday. Avanos Medical, Inc. has a 1 year low of $17.24 and a 1 year high of $25.36. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.28 and a quick ratio of 1.49. The business’s 50-day moving average is $23.55 and its 200-day moving average is $21.14. The company has a market capitalization of $1.07 billion, a price-to-earnings ratio of -17.45 and a beta of 0.91.

Avanos Medical (NYSE:AVNS) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.05. The firm had revenue of $171.70 million for the quarter, compared to analysts’ expectations of $170.67 million. Avanos Medical had a return on equity of 4.48% and a net margin of 1.13%. The company’s revenue for the quarter was up 1.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.24 EPS. Equities research analysts predict that Avanos Medical, Inc. will post 1.39 earnings per share for the current year.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.